Venous Thromboembolism after Hospital Discharge: Temporal Trends in Baseline Characteristics, Prevention, Treatment, and 90-day Outcomes
Authors:
- Benjamin BrennerBBBenjamin Brenner
- the RIETE InvestigatorsTIthe RIETE Investigators
- 17 October 2024
- journal article
- review article
- Published by Georg Thieme Verlag KG in Seminars in Thrombosis and Hemostasis
- Vol. 51 (03) , 301-311
Abstract
Venous thromboembolism (VTE) after hospital discharge poses a serious health risk. Assessments of patient characteristics, prophylaxis, treatment, outcomes, and over time changes lack consistency. Data on 16,901 hospitalized patients in the Registro Informatizado Enfermedad TromboEmbolica registry (2003–2022) were analyzed to evaluate trends in baseline characteristics, prophylaxis, treatments, and 90-day outcomes among medical (6,218) and surgical (10,683) patient cohorts. Multivariable logistic regression was used to assess the risks of the composite of fatal pulmonary embolism (PE) or recurrent VTE and major bleeding. The proportion of patients who presented with PE increased among medical (from 54 to 72%) and surgical patients (from 55 to 58%). Prophylaxis use increased in medical patients (from 53 to 71%), while decreasing in surgical patients (from 67 to 58%). Notably, the 90-day composite of fatal PE or recurrent VTE decreased in medical (from 3.9 to 1.8%) and surgical patients (from 2.9 to 1.2%; p < 0.001 for both). Conversely, major bleeding increased (3.1 to 4.5%) in medical patients (p = 0.008), with no change in surgical patients (from 2.5 to 2.4%). Risk-adjusted analysis showed a yearly decrease in the risk for the composite outcome (subhazard ratio [sHR]: 0.95; 95% confidence interval [CI]: 0.93–0.98) in medical and surgical patients and an increase in the risk for major bleeding in medical patients only (sHR: 1.04; 95% CI: 1.01–1.07). Results were consistent after excluding coronavirus disease 2019 patients. Over 20 years, the composite of fatal PE or recurrent VTE within 90 days had significantly decreased in VTE patients after hospitalization for medical or surgical care. Medical patients, however, exhibited an increase in major bleeding. B.B., I.T., B.B., and M.M. conceived and designed the study. B.B., I.T., B.B., R.V., G.P., R.T.M., M.L.P., J.P.E., M.G.P., and M.M. collected and/or interpreted the data. All authors revised the manuscript critically for important intellectual content and gave final approval of the manuscript submitted. * A full list of the RIETE investigators is given in the [Appendix]. Article published online: 17 October 2024 © 2024. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USAKeywords
This publication has 28 references indexed in Scilit:
- Trends and Risk Factors for Venous Thromboembolism Among Hospitalized Medical PatientsJAMA Network Open, 2022
- Efficacy and Safety Considerations With Dose-Reduced Direct Oral AnticoagulantsJAMA Cardiology, 2022
- Venous thromboembolismThe Lancet, 2021
- Predicting the risk for major bleeding in elderly patients with venous thromboembolism using the Charlson index. Findings from the RIETEJournal of Thrombosis and Thrombolysis, 2020
- 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancerThe Lancet Oncology, 2019
- Pulmonary Embolism Hospitalization, Readmission, and Mortality Rates in US Older Adults, 1999-2015JAMA, 2019
- Comparison of four scores to predict major bleeding in patients receiving anticoagulation for venous thromboembolism: findings from the RIETE registryInternal and Emergency Medicine, 2014
- Incidence of and Mortality from Venous Thromboembolism in a Real-world Population: The Q-VTE Study CohortThe American Journal of Medicine, 2013
- Identification of Quality of Care Deficiencies in Elderly Surgical Patients by Measuring Adherence to Process-Based Quality IndicatorsJournal of the American College of Surgeons, 2013
- Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional studyThe Lancet, 2008